Related Experiment Video
Updated: Aug 14, 2026
10:39
Qualitative and Quantitative Validation of Tools with Rating Scales Aimed at Assessing the Quality of University Service-Learning
Published on: August 29, 2025
Using qualitative evaluation in a feasibility study to improve and refine a complementary therapy intervention prior
Marsha Fonteyn1, Susan Bauer-Wu
1The Phyllis F. Cantor Center, Research in Nursing and Patient Care Services, Dana-Farber Cancer Institute, University of Massachusetts, Boston, MA, 44 Binney Street G220, Boston, MA 02115-6084, USA. marsha_fonteyn@dfci.harvard.edu
Complementary Therapies in Clinical Practice
|November 18, 2005
Summary
This study refined a mindfulness meditation (MM) intervention for stem cell transplant patients. Patient feedback from guided interviews improved the MM therapy, paving the way for future clinical trials.
Area of Science:
- Integrative Oncology
- Complementary and Alternative Medicine
- Qualitative Research Methods
Background:
- Feasibility studies are crucial for evaluating and refining complementary therapies.
- Stem cell/autologous bone marrow transplant (SC/ABMT) patients may benefit from supportive interventions.
- Mindfulness meditation (MM) is a complementary therapy with potential applications in supportive care.
Purpose of the Study:
- To assess the feasibility of a mindfulness meditation (MM) intervention in SC/ABMT patients.
- To gather patient feedback for refining the MM intervention.
- To inform the design of future randomized controlled trials.
Main Methods:
- Conducted guided interviews with 19 SC/ABMT patients participating in an MM feasibility study.
- Transcribed audiotapes of interviews.
- Utilized QRS NVivo software for qualitative data management and analysis.
Main Results:
- Identified patient preferences and suggestions for improving the MM intervention.
- Qualitative data provided rich insights into patient experiences.
- The MM intervention was refined based on participant feedback.
Conclusions:
- Qualitative evaluation of complementary therapies is essential for intervention refinement.
- Preliminary qualitative work can optimize resource allocation for future rigorous trials.
- Refined MM intervention is planned for further testing in a randomized controlled trial.
Related Concept Videos
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:15Nursing Evaluation
The evaluation stage signals the end of the nursing process. The nurse gathers evaluative data to assess whether or not the patient has attained the expected results. Whereas the nurse collects data in the nursing assessment to identify the patient's health concerns, the evaluation stage data determines if the indicated health issues are resolved. Evaluative data collection includes two sections: the data acquired to evaluate patient outcomes and the time criteria for data collection.
Section...
Section...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:28Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
01:20Nursing Process for Patient and Caregiver Teaching III: Evaluation and Documentation
Evaluation of the teaching process enables the nurse to determine if the patient's learning needs were met and if training was effective. If the expected outcomes are not met, the care plan is revised, and additional education or reinforcement is provided. Nurses can ask questions after the session or obtain feedback to assess the patient's understanding of the topic.
Nurses can use several methods to evaluate patient outcomes. For example, oral questions can assess cognitive learning, patient...
Nurses can use several methods to evaluate patient outcomes. For example, oral questions can assess cognitive learning, patient...